Elise Biopharma
Cambridge, MA (US); GMP facility also in Montreal, Canada
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Elise Biopharma
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Cambridge, MA (US); GMP facility also in Montreal, Canada
- Modalities
- Microbial Fermentation (E. coli, Pichia, Bacillus, Streptomyces, Corynebacterium), Recombinant Protein, mRNA / LNP, Plasmid DNA, AAV, Lentiviral Vector, Cell Therapy (CAR-T, NK), Oncolytic Virus, Exosome / Extracellular Vesicle, Radiopharmaceuticals (Lu-177, Ac-225), IVD / Diagnostics, Animal Health Biologics
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Elise Biopharma
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesMicrobial Fermentation (E. coli, Pichia, Bacillus, Streptomyces, Corynebacterium), Recombinant Protein, mRNA / LNP, Plasmid DNA, AAV, Lentiviral Vector, Cell Therapy (CAR-T, NK), Oncolytic Virus, Exosome / Extracellular Vesicle, Radiopharmaceuticals (Lu-177, Ac-225), IVD / Diagnostics, Animal Health Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (12 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Broad modality coverage (12 modalities)
Frequently Asked Questions About Elise Biopharma
What is Elise Biopharma's CDMO Signal Score?
Elise Biopharma has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Elise Biopharma for a manufacturing program?
Use the free AI matchmaker to compare Elise Biopharma against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Catalent
Bagsværd, Denmark (operating under Novo Holdings)
Signal Score: 76.5
Monoclonal Antibody, Recombinant Protein, ADC, AAV, mRNA, Plasmid DNA, Fill-Finish
Catalent (Novo Holdings)
Harmans, MD · Gosselies, BE
Signal Score: 75.1
Monoclonal Antibody, Recombinant Protein, ADC, AAV, mRNA, Plasmid DNA, Fill-Finish
Porton Advanced
Cranbury, NJ
Lentiviral Vector, AAV, Adenoviral Vector, Plasmid DNA, CAR-T, TCR-T, CAR-NK, HSC, Exosome, mRNA
Pharmaron Biologics (Liverpool)
Liverpool, United Kingdom
AAV, Lentiviral, Adenoviral, Plasmid DNA, Recombinant Protein, Vaccines
Canton Biologics
Guangzhou, China
Monoclonal Antibody, Bispecific Antibody, Recombinant Protein, Fusion Protein, Plasmid DNA, Lentiviral, CAR-T, AAV